Serum Carboxylesterase Activity in Various Strains of Rats: Sensitivity to Inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide)

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 1990 Jan 1

PMID 2403290

Citations 2

Authors

J G Clement

N Erhardt

Affiliations

Soon will be listed here.

Abstract

Rodents are relatively insensitive to the neurotoxic effects of various organophosphorus compounds. The purpose of this investigation was to determine if differences in inactivation of CBDP could explain the strain differences in the sensitivity to neurotoxicity following administration of TOCP (tri-o-cresyl phosphate) observed by Carrington and Abou-Donia (1988). Serum carboxylesterase but not cholinesterase is an important detoxification route for organophosphates. Serum carboxylesterase and cholinesterase activity were significantly different (p less than 0.05) among the various strains of rats. The rank order of carboxylesterase activity was Sprague Dawley (6158 nmole/ml serum/min) greater than Long Evans (5589) greater than Fischer 344 (5010) whereas the rank order for cholinesterase activity was Fischer 344 greater than Sprague Dawley greater than Long Evans. TOCP is metabolized to the active neurotoxicant CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide). The ED50 for CBDP inhibition of serum carboxylesterase activity was found to vary considerably for the various strains of rats. The rank order of CBDP ED50 concentration in the various strains was Fischer 344 (437 microM) greater than Long Evans (339 microM) greater than Sprague Dawley (78 microM), indicating that there was a difference between the carboxylesterase of the various strains with regard to interaction with CBDP. It is suggested that the differences in the quantity of serum carboxylesterase combined with the differences in the interaction of the inhibitor with the enzyme(s) may be responsible for the strain differences observed by Carrington and Abou-Donia (1988).

Citing Articles

Conjugation to Ascorbic Acid Enhances Brain Availability of Losartan Carboxylic Acid and Protects Against Parkinsonism in Rats.

Subudhi B, Sahu P, Singh V, Prusty S AAPS J. 2018; 20(6):110.

PMID: 30350232 DOI: 10.1208/s12248-018-0270-1.

Ray A, Liu J, Ayoubi P, Pope C Toxicol Appl Pharmacol. 2010; 248(2):144-55.

PMID: 20691718 PMC: 2946483. DOI: 10.1016/j.taap.2010.07.026.

References

Grubic Z, Sket D, Brzin M . Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases. Arch Toxicol. 1988; 62(5):398-9. DOI: 10.1007/BF00293631. View

Fonnum F, Sterri S, Aas P, Johnsen H . Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes. Fundam Appl Toxicol. 1985; 5(6 Pt 2):S29-38. DOI: 10.1016/0272-0590(85)90112-5. View

Jimmerson V, Shih T, Maxwell D, Mailman R . Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat. Toxicol Lett. 1989; 48(1):93-103. DOI: 10.1016/0378-4274(89)90190-2. View

Abou-Donia M, Nomeir A . The role of pharmacokinetics and metabolism in species sensitivity to neurotoxic agents. Fundam Appl Toxicol. 1986; 6(2):190-207. View

Clement J . Role of aliesterase in organophosphate poisoning. Fundam Appl Toxicol. 1984; 4(2 Pt 2):S96-105. DOI: 10.1016/0272-0590(84)90141-6. View

Boskovic B . The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy. Arch Toxicol. 1979; 42(3):207-16. View

Carrington C, Abou-Donia M . Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate. J Toxicol Environ Health. 1988; 25(3):259-68. DOI: 10.1080/15287398809531208. View

Clement J . Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice. Biochem Pharmacol. 1984; 33(23):3807-11. DOI: 10.1016/0006-2952(84)90044-3. View

Junge W, Krisch K . The carboxylesterases/amidases of mammalian liver and their possible significance. CRC Crit Rev Toxicol. 1975; 3(4):371-435. DOI: 10.3109/10408447509079864. View

10.

Clement J . Sodium pentobarbital alteration of the toxicity and distribution of soman (pinacolyl methylphosphonofluoridate) in mice. Biochem Pharmacol. 1984; 33(4):683-5. DOI: 10.1016/0006-2952(84)90326-5. View

11.

Carrington C . Prophylaxis and the mechanism for the initiation of organophosphorous compound-induced delayed neurotoxicity. Arch Toxicol. 1989; 63(3):165-72. DOI: 10.1007/BF00316365. View

12.

Novak R, Padilla S . An in vitro comparison of rat and chicken brain neurotoxic esterase. Fundam Appl Toxicol. 1986; 6(3):464-71. DOI: 10.1016/0272-0590(86)90220-4. View

13.

Eto M, Casida J, Eto T . Hydroxylation and cyclization reactions involved in the metabolism of tri-o-cresyl phosphate. Biochem Pharmacol. 1962; 11:337-52. DOI: 10.1016/0006-2952(62)90056-4. View

14.

Maxwell D, Brecht K, Lenz D, ONeill B . Effect of carboxylesterase inhibition on carbamate protection against soman toxicity. J Pharmacol Exp Ther. 1988; 246(3):986-91. View

15.

Ellman G, COURTNEY K, ANDRES Jr V, FEATHER-STONE R . A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7:88-95. DOI: 10.1016/0006-2952(61)90145-9. View